MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysarthria"

  • 2025 International Congress

    Quantitative evaluation of speech characteristics in Assessment of Motor Speech for Dysarthria (AMSD) using acoustic analysis

    R. Kotani, Y. Shirota, A. Seto, Y. Nagashima, H. Onodera, K. Yatani, M. Hamada, T. Toda (Tokyo, Japan)

    Objective: This study aims to extract acoustic features from speech data obtained from patients undergoing the Assessment of Motor Speech for Dysarthria (AMSD), a clinical…
  • 2025 International Congress

    Schindler Disease (a Rare Autosomal Recessive Lysosomal Storage Disorder)

    SH. Elgamal, E. Fahmy, M. Ragab (Kafrelsheikh, Egypt)

    Objective: This case report discusses the diagnostic difficulties and treatment strategies for Schindler disease type III and provides insightful information on its clinical manifestations Background:…
  • 2024 International Congress

    Effects on Speech After the Use of Swallow Against Resistance Exercise Device in Parkinson’s Disease Patients

    R. Lee, H. Hassan, E. Jackowiak, R. Brennan, M. Kern, R. Shaker (Milwaukee, USA)

    Objective: To evaluate the effect on speech after a strength training exercise targeting the swallowing biomechanics in Parkinson’s disease (PD) patients. Background: Dysarthria and dysphagia…
  • 2024 International Congress

    Examining the Effects of Deep Brain Stimulation on Speech in Parkinson’s Disease

    H. Kabakoff, A. Mogilner, M. Pourfar, A. Flinker (Brooklyn, USA)

    Objective: The current goal is to use pilot data to explain speech changes in patients with Parkinson’s disease (PD) who have Deep Brain Stimulation (DBS)…
  • 2024 International Congress

    Detecting impulsivity through speech in patients with Parkinson’s Disease: A principle proof study

    T. Thies, E. Mallick, S. Jost, J. Tröger, M. Barbe (Cologne, Germany)

    Objective: To identify speech biomarkers to assess impulsivity in patients with Parkinson's disease (PwPD). Background: Although PD mainly presents with motor symptoms, the burden of…
  • 2024 International Congress

    Craniofacial Myoclonus: A Disabling Complication of Amantadine Therapy

    S. Bhushan, Mph, S. Brillman, Md (Palo Alto, USA)

    Objective: We describe a patient who developed amantadine-induced craniofacial myoclonus with speech impairment. Few cases have been reported [1], thus we offer an additional case…
  • 2024 International Congress

    The Effect of Genotype on Voice & Swallowing in Parkinson’s Disease: A Parkinson’s Progression Markers Initiative Study

    M. Dumican, T. Reyers, A. Malczewski (Kalamazoo, USA)

    Objective: The objectives of this project were twofold: 1. Determine how genotypes of Parkinson’s Disease (PD) affect voice & swallowing function, and 2. Examine how…
  • 2024 International Congress

    Breaking Barriers to Offer Evidence-Based Services for Patients with Parkinson’s Disease in South Africa

    S. Govender, S. Haffejee (Johannesburg, South Africa)

    Objective: To provide evidence-based services for patients with Parkinson’s disease considering the burden of disease in South Africa (SA) and access, socio economic and technology…
  • 2024 International Congress

    Effect of Levodopa therapy in Hypokinetic Dysarthria in Parkinson’s Disease

    E. Smaoui, N. Farhat, S. Daoud, K. Moalla, N. Bouattour, M. Damak, C. Mhiri (Sfax, Tunisia)

    Objective: The objective of this study was to assess the possible changes in acoustic speech parameters in a cohort of PD patients after acute levodopa…
  • 2024 International Congress

    Correlating Dysarthria with MRI Findings in Temporal Lobe Glioma: Impact of Steroid Therapy on Cerebral Edema

    D. Valle, L. Valad, S. Jiang, B. Carr (Gainesville, USA)

    Objective: Examine the relationship between dysarthria and MRI findings in a patient with left posterior mesial temporal lobe glioma and further evaluate the role of corticosteroid therapy in mitigating associated cerebral…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley